During the past decade, National Institute of Mental Health conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Institute of Mental Health" #1 sponsor was "National Institute of Mental Health, Czech Republic" with 6 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "COMPASS Pathways" with 2 trials sponsored and "ACADIA Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute of Mental Health" #1 collaborator was "Czech Clinical Research Infrastructure Network" with 1 trials as a collaborator, "Czech Health Research Council" with 1 trials as a collaborator, "Mindpax s.r.o., Czech Republic" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "National Institute of Mental Health" are "Schizophrenia" (4 trials), "Depressive Disorder, Major" (3 trials), "Treatment Resistant Depression" (3 trials), "Acrophobia" (1 trials) and "Anhedonia" (1 trials). Many other conditions were trialed in "National Institute of Mental Health" in a lesser frequency.

Most popular intervention types in "National Institute of Mental Health" are "Drug" (10 trials), "Behavioral" (3 trials), "Other" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Aticaprant" (2 trials), "Enhanced Treatment As Usual" (2 trials), "Mom´s Supporting Mom" (2 trials) and "Psilocybin" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Institute of Mental Health" are 13 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "National Institute of Mental Health". undefined are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in National Institute of Mental Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Institute of Mental Health, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".